Jacobsen, Malte ORCID: 0000-0003-0780-0003, Rottmann, Pauline, Dembek, Till A., Gerke, Anna L., Gholamipoor, Rahil, Blum, Christopher, Hartmann, Niels-Ulrik, Verket, Marlo ORCID: 0000-0002-3361-3722, Kaivers, Jennifer, Jager, Paul ORCID: 0000-0001-9250-2064, Baermann, Ben-Niklas, Heinemann, Lutz, Marx, Nikolaus, Muller-Wieland, Dirk, Kollmann, Markus, Seyfarth, Melchior and Kobbe, Guido (2022). Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies. JCO Clin. Cancer Info., 6. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2473-4276

Full text not available from this repository.

Abstract

PURPOSE Intensive treatment protocols for aggressive hematologic malignancies harbor a high risk of serious clinical complications, such as infections. Current techniques of monitoring vital signs to detect such complications are cumbersome and often fail to diagnose them early. Continuousmonitoring of vital signs and physical activity bymeans of an upper arm medical wearable allowing 24/7 streaming of such parameters may be a promising alternative. METHODS This single-arm, single-center observational trial evaluated symptom-related patient-reported outcomes and feasibility of a wearable-based remote patient monitoring. All wearable data were reviewed retrospectively and were not available to the patient or clinical staff. A total of 79 patients (54 inpatients and 25 outpatients) participated and received standard-of-care treatment for a hematologic malignancy. In addition, the wearable was continuously worn and self-managed by the patient to record multiple parameters such as heart rate, oxygen saturation, and physical activity. RESULTS Fifty-one patients (94.4%) in the inpatient cohort and 16 (64.0%) in the outpatient cohort reported gastrointestinal symptoms (diarrhea, nausea, and emesis), pain, dyspnea, or shivering in at least one visit. With the wearable, vital signs and physical activity were recorded for a total of 1,304.8 days. Recordings accounted for 78.0% (63.0-88.5; median [interquartile range]) of the potential recording time for the inpatient cohort and 84.6% (76.3-90.2) for the outpatient cohort. Adherence to the wearable was comparable in both cohorts, but decreased moderately over time during the trial. CONCLUSION A high adherence to the wearable was observed in patients on intensive treatment protocols for a hematologic malignancy who experience high symptom burden. Remote patient monitoring of vital signs and physical activity was demonstrated to be feasible and of primarily sufficient quality. (C) 2022 by American Society of Clinical Oncology

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Jacobsen, MalteUNSPECIFIEDorcid.org/0000-0003-0780-0003UNSPECIFIED
Rottmann, PaulineUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dembek, Till A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gerke, Anna L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gholamipoor, RahilUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Blum, ChristopherUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hartmann, Niels-UlrikUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Verket, MarloUNSPECIFIEDorcid.org/0000-0002-3361-3722UNSPECIFIED
Kaivers, JenniferUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jager, PaulUNSPECIFIEDorcid.org/0000-0001-9250-2064UNSPECIFIED
Baermann, Ben-NiklasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heinemann, LutzUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Marx, NikolausUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Muller-Wieland, DirkUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kollmann, MarkusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Seyfarth, MelchiorUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kobbe, GuidoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-687263
DOI: 10.1200/CCI.21.00126
Journal or Publication Title: JCO Clin. Cancer Info.
Volume: 6
Date: 2022
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Place of Publication: PHILADELPHIA
ISSN: 2473-4276
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/68726

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item